Femasys Stock Plunged 24% Today - Here's Why?
Portfolio Pulse from Ryan Gustafson
Femasys Inc. (NASDAQ:FEMY) shares fell by 24% on Wednesday, following a surge in price on Tuesday due to the announcement of FDA 510(k) clearance for FemaSeed, an infertility treatment. The stock experienced an above-average trading volume of 15.73 million shares compared to its average volume of 6.76 million.
September 27, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Femasys Inc. shares fell by 24% following a surge due to FDA clearance for FemaSeed. The stock saw an above-average trading volume.
The sharp drop in Femasys Inc.'s stock price is likely due to investors taking profits after the stock's significant surge on Tuesday. The high trading volume indicates a high level of investor interest, which could lead to increased volatility in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100